Key Takeaways
- • Daryl Tol, President of General Catalyst's HATCo, has stepped down, according to Modern Healthcare News reporting dated October 27, 2026.
- • The departure is reported in the Health Tech section of Modern Healthcare, which covers the health technology investment and operating landscape.
- • The primary source provides no further detail on the reasons for the departure, a successor, or HATCo's strategic direction.
Summary
Daryl Tol, president of HATCo, the health-care-focused unit associated with venture firm General Catalyst, has stepped down from the role, Modern Healthcare reported on October 27, 2026. The report was written by Joyce Famakinwa and appears in the publication's Health Tech coverage.
The primary article confirms the leadership change but does not disclose the reasons for Tol's departure, the timing of his exit beyond the report date, or who will succeed him. It also does not describe HATCo's assets, portfolio, or strategy in detail. Readers seeking the implications for General Catalyst's health-care investment activity should monitor subsequent company or trade-press disclosures.
The primary article confirms the leadership change but does not disclose the reasons for Tol's departure, the timing of his exit beyond the report date, or who will succeed him. It also does not describe HATCo's assets, portfolio, or strategy in detail. Readers seeking the implications for General Catalyst's health-care investment activity should monitor subsequent company or trade-press disclosures.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.